For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. We are guided by world-class scientists and business leaders whose great passion for innovation is equaled only by their focus and commitment to discover, develop and deliver medicines to the patients who depend on us.
View Top Employees from Ionis Pharmaceuticals, Inc.Looking for a particular Ionis Pharmaceuticals, Inc. employee's phone or email?
The Ionis Pharmaceuticals, Inc. annual revenue was $599 million in 2024.
Brett Monia is the CEO of Ionis Pharmaceuticals, Inc..
919 people are employed at Ionis Pharmaceuticals, Inc..
Ionis Pharmaceuticals, Inc. is based in Carlsbad, California.
The NAICS codes for Ionis Pharmaceuticals, Inc. are [54, 541, 54138, 5413].
The SIC codes for Ionis Pharmaceuticals, Inc. are [87, 8734, 873].